Remdesivir under the brand name Desrem in India for treatment of coronavirus patients. The drug is approved for the treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalized with severe presentations of the disease, Mylan said.
The company also launched a 24/7 helpline where patients and healthcare practitioners can access information about Mylan’s Remdesivir and its availability.
Patients and healthcare practitioners can access information about the availability of Desrem in India through Mylan’s 24/7 national helpline number, +91.78299.80066, the company said.Mylan will manufacture Desrem in its injectable facility in Bangalore, which will work to service the demand in India and other export.